Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses

被引：11

作者：

Ansaldi, F ^{[1
]}

Bacilieri, S ^{[1
]}

Banfi, F ^{[1
]}

Durando, P ^{[1
]}

Sticchi, L ^{[1
]}

Icardi, G ^{[1
]}

Gasparini, R ^{[1
]}

机构：

[1] Univ Genoa, Dept Hlth Sci, I-16100 Genoa, Italy

来源：

CLINICAL AND VACCINE IMMUNOLOGY | 2006年 / 13卷 / 01期

关键词：

D O I：

10.1128/CVI.13.1.162-164.2006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Evaluation of the antibody responses induced by the 2004-2005 influenza vaccine strain against the homologous variant, the 2004-2005 field isolates, and a previous circulating strain showed that a correlation between neutralizing and hemagglutination-inhibiting activities exists only when the antigen is very close to the vaccine strain.

引用

页码：162 / 164

页数：3

共 21 条

[1] Overcoming original (antigenic) sin
Anderson, DE
Carlos, MP
Nguyen, L
Torres, JV
[J]. CLINICAL IMMUNOLOGY, 2001, 101 (02) : 152 - 157
[2] [Anonymous], MMWR RECOMM REP
[3] New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season
Ansaldi, F
Icardi, G
Gasparini, R
Campello, C
Puzelli, S
Bella, A
Donatelli, I
Salmaso, S
Crovari, P
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (06) : 3027 - 3029
[4] Antigenic characterisation of influenza B virus with a new microneutralisation assay: Comparison to haemagglutination and sequence analysis
Ansaldi, F
Bacilieri, S
Amicizia, D
Valle, L
Banfi, F
Durando, P
Sticchi, L
Gasparini, R
Icardi, G
Crovari, P
[J]. JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (01) : 141 - 146
[5] Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season
Ansaldi, F
D'Agaro, P
de Florentiis, D
Puzelli, S
Lin, YP
Gregory, V
Bennett, M
Donatelli, I
Gasparini, R
Crovari, P
Hay, A
Campello, C
[J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) : 463 - 469
[6] NEUTRALIZATION ENZYME-IMMUNOASSAY FOR INFLUENZA-VIRUS
BENNE, CA
HARMSEN, M
DEJONG, JC
KRAAIJEVELD, CA
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) : 987 - 990
[7] Seroprotection rate, mean fold increase, seroconversion rate:: which parameter adequately expresses seroresponse to influenza vaccination?
Beyer, WEP
Palache, AM
Lüchters, G
Nauta, J
Osterhaus, ADME
[J]. VIRUS RESEARCH, 2004, 103 (1-2) : 125 - 132
[8] Influenza A (H3N2) outbreak, Nepal
Daum, LT
Shaw, MW
Klimov, AI
Canas, LC
Macias, EA
Niemeyer, D
Chambers, JP
Renthal, R
Shrestha, SK
Acharya, RP
Huzdar, SP
Rimal, N
Myint, KS
Gould, P
[J]. EMERGING INFECTIOUS DISEASES, 2005, 11 (08) : 1186 - 1191
[9] de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt
[10] 94::AID-JMV15&gt

← 1 2 3 →